New Matter Podcast

Current Episode

In this episode, we're joined by Lorna Ewart, PhD, CSO of Emulate, to discuss the company's SLAS 2026 New Product Award-winning product: AVA™ Emulation System. AVA™ is a self-contained, benchtop organ-on-a-chip platform that runs 96 chips simultaneously.

Lorna shares how the device was developed and its impact on drug discovery and organ-on-a-chip technology.

Key Learning Points:

• Development of the AVA emulation system
• Applications of the AVA platform in drug discovery
• Impact of organ-on-a-chip technology on biomedical research

About Emulate

Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate’s Organ-Chip platforms, consumables, and organ models help the world’s leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies.